Table 1.

Clinical, radiological and pathological data of the study cohort.

Type of pituitary tumor and distribution (Dx until and after 18 years)	Females (%)	Median age (min–max)	Median tumor diameter mm (min–max)	Giant adenomas (%)	Available tumors
Somatotropinoma	43 (58)	29 (18–40)	24 (11–61)	7 (9.4)	8
n = 74; 56.0%
≤18 years = 1	1 (100)	18	20	0	0
>18 years = 73	42 (58)	29 (20–40)	25 (11–61)	7	8
Prolactinoma	27 (71)	23 (11–40)	19 (10–81)	12 (31.6)	2
n = 38; 28.8%
≤18 years = 8	5 (63)	17 (11–18)	19 (14–60)	3	0
>18 years = 30	22 (73)	25 (19–40)	19.5 (10–81)	9	2
NFPA	6 (60)	30.5 (11–37)	27 (12–50)	1 (10)	0
n = 10; 7.6%
≤18 years = 2	0	12.5 (11–14)	22*	0	0
>18 years = 8	6 (75)	32.5 (22–37)	28.5 (12–50)	1	0
Cushing’s disease	8 (80)	21.5 (9–39)	12 (6–35)	0	2
n = 10; 7.6%
≤18 years = 4	2 (50)	14 (9–16)	10 (6–11)	0	1
>18 years = 6	6 (100)	25 (21–39)	15.5 (12–35)	0	1
Total	84 (63)	28 (9–40)	22 (6–81)	20 (14.5)	12
n = 132

*Only one patient had tumor diameter available.

Dx, diagnosis; NFPA, non-functioning pituitary adenoma.